T2S Group Holding Makes Historic Market Entry
T2S Group Holding, a leader in Morocco's medical technology sector, has officially made its debut on the Casablanca Stock Exchange, marking a significant milestone for the nation’s financial landscape and its burgeoning healthcare market. This event represents the first initial public offering (IPO) of the year 2026 on the exchange, an indication of robust investor interest and confidence in the MedTech industry. The IPO was a resounding success, raising approximately MAD 1.1 billion, which consisted of a MAD 350 million capital increase combined with a MAD 750 million share sale, highlighting the company's strong market position and investor appeal.
With more than 110,000 investors subscribing to the IPO, the offering was oversubscribed by an impressive factor of 43, showcasing the high demand for shares in T2S. The shares were priced at MAD 223, with a total of 1,569,506 new shares issued alongside 3,363,228 existing shares sold. This level of engagement from the investment community underscores the growing optimism surrounding Morocco's healthcare sector.
A Vision for Growth and Innovation
Founded in 1992 by Abderraouf Sordo, T2S Group has evolved into a significant player in the MedTech arena, employing over 410 professionals and establishing partnerships with renowned international companies such as GE HealthCare, BioMérieux, Accuray, and Boston Scientific. The organization specializes in supplying, installing, and maintaining essential medical equipment for both public and private healthcare providers. Additionally, T2S Group is involved in the production of radiopharmaceuticals through its subsidiary, Cyclopharma, and is advancing healthcare solutions via AI-powered hospital software developed by its subsidiary, Binarios.
In 2025, T2S reported revenues amounting to MAD 1.76 billion, with 46% of this income derived from recurring activities, indicating a stable revenue model. The company has ambitious plans to increase its annual revenue to MAD 4.17 billion by 2030. To achieve this, T2S Group intends to utilize the proceeds from its IPO to accelerate innovation, expand its reach across Africa, enhance local manufacturing capabilities, and pursue strategic acquisitions. Currently, T2S operates in over 20 African countries, and the planned expansion will further solidify its presence on the continent.
As reported by en.yabiladi.com.
